Ionis Pharmaceuticals Inc
IONS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000874015
In the last 90 days, Ionis Pharmaceuticals Inc insiders filed 1 open-market purchase and 3 sales; 515 institutions reported holding it in 13F filings for Q2 2026, worth $14.3B in total; ARK Invest is the only superinvestor holding it.
Q1 2022 vs. Q4 2021
How the institutions holding Ionis Pharmaceuticals Inc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 341 | 5 | 333 | −3 |
| Shares | 123.2M | 5.27K | 125.0M | +1.76M (+1.4%) |
| Value | $3.75B | $160.0K | $4.63B | +$876.1M (+23.4%) |
5 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (47)
Institutions that held Ionis Pharmaceuticals Inc at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (50)
Institutions that held Ionis Pharmaceuticals Inc at the end of Q4 2021 and filed for Q1 2022 without it.
Not filed for Q1 2022 yet (5)
Institutions that held Ionis Pharmaceuticals Inc at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| NEXT Financial Group, Inc | 2,893 | $88.0K |
| Harbour Investments, Inc. | 1,260 | $38.0K |
| Carroll Financial Associates, Inc. | 793 | $24.0K |
| Reilly Financial Advisors, LLC | 220 | $7.00K |
| Bell Investment Advisors, Inc | 102 | $3.00K |